The first medically-approved penile implants
(prostheses) were developed and used in the treatment of ED in 1973.
According to Dan Bolton of San Francisco, who filed one of the recent class actions, "The failure rate of penile implants
may be in excess of 30 percent, and likely significantly higher.
According to attorney Lewis Saul of Bethesda, Maryland, none of the penile implant
devices ever was thoroughly investigated by the FDA.
A penile implant
may be a viable alternative for these men because it is suggested that only 10 percent of men who undergo a non-nerve sparing radical prostatectomy surgery can benefit from oral ED therapy.
AMS developed InhibiZone to minimize infections from penile implant
A penile implant
is the only option that actually cures ED, particularly valuable for men who are impotent as a result of diabetes or prostate cancer surgery.
American Medical Systems, headquartered in Minnetonka, Minnesota, is the world leader in the penile implant
market, with a series of semi-rigid malleable prostheses and a complete range of more naturally functioning inflatable prostheses.
A new penile implant
designed to treat men living with Drug Resistant Erectile Dysfunction (DRED) was introduced here to doctors attending the 10th World Congress of the International Society for Sexual and Impotence Research (ISSIR).
New Titan(tm) Penile Implant
Designed for Men With Drug Resistant
Mentor Corporation (Nasdaq:MNTR), announced today that its new penile implant
featuring a hydrophilic surface has been approved by the FDA for sale and marketing in the United States.
The Resist technology brings an improvement that is the first of its kind for a penile implant
In the past, men who failed injection therapy were often offered penile implant
surgery as their only option.